Background: Multiple intravitreal pharmacotherapies including different anti-vascular endothelial growth factors (VEGF), intravitreal steroids, and combined therapy with anti-VEGF and steroids are available for patients with macular edema secondary to retinal vein occlusion (RVO). However, the recommendation of multiple therapies remains unknown. This study aims to evaluate the efficacy and safety of multiple intravitreal pharmacotherapies in patients with macular edema secondary to RVO.

Methods: We will systematically search the PubMed, Embase, and the Cochrane library for eligible studies. Randomized controlled trials (RCTs) with intravitreal pharmacotherapies for patients with macular edema secondary to RVO will be included. The Cochrane Collaboration's tool will be used to assess the risk of bias in the randomized trial. The primary outcome is the mean change in BCVA from baseline. The secondary outcomes are the proportion of patients who gained ≥15 letters in BCVA from baseline, the mean change in central retinal thickness from baseline and the number of serious adverse events.

Results: The result will obtain a comprehensive treatment recommendation for macular edema secondary to RVO.

Conclusion: The results of the network meta-analysis will be submitted in a peer-reviewed journal for publication.

Ethical Statement: This article does not contain any studies with human or animal subjects performed by any of the authors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505385PMC
http://dx.doi.org/10.1097/MD.0000000000022267DOI Listing

Publication Analysis

Top Keywords

macular edema
20
edema secondary
20
intravitreal pharmacotherapies
12
patients macular
12
secondary retinal
8
retinal vein
8
vein occlusion
8
network meta-analysis
8
multiple intravitreal
8
pharmacotherapies patients
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!